Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms-Reference-Cited by-同舟云学术

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

Published:2021-06-12 Issue:7 Volume:5 Page:e593
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Secardin Lise,Gomez Limia Cintia,da Silva-Benedito Suzana,Lordier Larissa,El-Khoury Mira,Marty Caroline,Ianotto Jean-Christophe,Raslova Hana,Constantinescu Stefan N.,Bonamino Martín Hernán,Vainchenker William,Monte-Mor Barbara,Di Stefano Antonio,Plo Isabelle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference42 articles.

1. Somatic mutations of calreticulin in myeloproliferative neoplasms.;Klampfl;N Engl J Med,2013

2. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.;Nangalia;N Engl J Med,2013

3. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.;Cabagnols;Leukemia,2015

4. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.;Pietra;Leukemia,2016

5. Type 1 versus type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.;Tefferi;Am J Hematol,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis;Haematologica;2023-02-16

2. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis;2022-09-03

3. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies;Cells;2021-11-19

4. CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes;Stem Cell Reports;2021-11

5. CALR frameshift mutations in MPN patient-derived iPS cells accelerate maturation of megakaryocytes;2021-07-05